Where Does Immunoprecise Antibodies Ltd (IPA) Stock Fall in the Biotechnology Field After It Is Higher By 47.95% This Week?

Immunoprecise Antibodies Ltd (IPA) is near the top in its industry group according to InvestorsObserver. IPA gets an overall rating of 64. That means it scores higher than 64 percent of stocks. Immunoprecise Antibodies Ltd gets a 80 rank in the Biotechnology industry. Biotechnology is number 54 out of 148 industries.

IPA has an Overall Score of 64. Find out what this means to you and get the rest of the rankings on IPA!

See Full IPA Report

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 64 would rank higher than 64 percent of all stocks. These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Immunoprecise Antibodies Ltd Stock Today?

Immunoprecise Antibodies Ltd (IPA) stock is lower by -6.49% while the S&P 500 is higher by 0.39% as of 1:32 PM on Wednesday, Nov 1. IPA is lower by -$0.15 from the previous closing price of $2.31 on volume of 133,648 shares. Over the past year the S&P 500 is higher by 9.18% while IPA is lower by -56.89%. IPA lost -$0.60 per share the over the last 12 months. Click Here to get the full Stock Report for Immunoprecise Antibodies Ltd stock.